In the era of Direct Acting Antiviral Drugs (DAAs) for Hepatitis C virus (HCV) management, nursing role and their effect on outcome is still underestimated. Aim of the work: Therefore, this study aimed to evaluate the effect of nursing intervention on outcomes for cirrhotic patients receiving DAAs. Patients and method: Quasiexperimental research design was used to conduct this study and designed at the Unit of Treatment of Viral Hepatitis at Assiut Health Directorate to enroll patients with HCV infection and eligible for treatment with DAAs (n=30) and were subjected to nursing knowledge evaluation tools. Two types for tools were applied; Tool (1) patient assessment sheet and Tool (II): (Nursing intervention sheet). Another control group (n=30). Tools were applied in 3 phases; preparatory, implementation and evaluation phase, both pretreatment and post treatment over a six months period. Results: the majority of patients of both study groups were males, farmers, illiterate, and came from rural areas with statistically significant difference. The majority of study group (96.6%) had unsatisfactory knowledge scores regarding knowledge of hepatitis C ,nutrition and treatment, while (67.6%) had satisfactory after implementation of the nursing intervention. Conclusion: The nursing intervention had statistically significant beneficial effects on improving patient's outcomes Recommendation: Providing training program and replication of this study on larger probability sample is highly recommended.
Introduction
Hepatitis C virus (HCV) infection continues to be an important global health problem and is one of the main causes of chronic liver disease worldwide .It is a hepatotropic viral infection caused by HCV, which is a major causes of cirrhosis, liver failure, hepatocellular carcinoma and the most common indication for liver transplantation (American association for the Study of Liver Diseases AASLD, 2012) Liver Cirrhosis is considered as one of the major health issues as it is one of the most important causes of death in the world. Liver cirrhosis is also defined as a chronic, progressive disease of the liver characterized by necrosis of liver cell and regeneration; Fibrotic bands of connective tissue that impair the flow of blood and lymph and distort the normal liver structure (Goldberg & Chopra, 2014). Decompensated cirrhosis: means that, the liver is extensively scarred and unable to function properly. People with decompensated cirrhosis eventually develop many symptoms and complications that can be life threatening as bleeding esophageal or gastric varices, hepatic encephalopathy, hepatorenal syndrome and HCC (Christopher, 2011). In general, every patient with HCV infection should receive antiviral therapy, because patients who are cured of their HCV infection will benefit with reduction in the risk of liver -related morbidity and mortality (Alan, 2015) . Treatment of HCV infection has 2 goals. The first is to cure HCV via a sustained elimination of the virus; sustained elimination of HCV is achieved if Polymers Chain Reaction (PCR) remains negative six month after the end of treatment sustained virolgical response SVR. The infection is cured in more than 99% of patients who achieve an SVR. The SVR is generally associated with resolution of liver disease in patients without cirrhosis. The second goal is to prevent progression to cirrhosis, HCC, and decompensated a liver disease which requires liver transplantation. Recent data suggest that the risk of HCC and all-cause mortality is significantly reduced, but not eliminated, in cirrhotic patients who clear HCV compared to untreated patients and those without sustained virological responders. (Van der Meer, et al., (2012) . The development of the direct acting antiviral drugs (DAAs) for treatment of CHC represent major advance in this issue. These new agents have high efficacy rates, short treatment duration, and minimal tolerable adverse effects. The development of these DAAs has rapidly evolved over the past 5 years and has radically changed the HCV treatment paradigm to allow interferon-free regimens, of which several are now approved and available in clinical practice in many countries (Bartenschlager, et al., 2013). Critical care nursing today needs to define basic clinical guidelines that are needed not only to define what constitutes safe practice, but also to guide nurse's decision making. Good clinical guidelines can change the process of health care and improve patient s outcomes.in addition; clinical guidelines can be used as educational and training tools for the critical care nurses (World Health Organization , 2012). Operational definition of outcomes Outcome for patients who are receiving DAAs for CHC is intended to improve the patient's management from the diagnosis to end of the course of antiviral therapy and during follow up. This includes maintaining physical activity, recognizing activity limitations, following dietary modifications, maintaining adequate nutrition, preventing complications, enhancing self-concept, and accepting the situation .
Significance of the study
Liver cirrhosis is considered a health problem in various countries and regions, in the USA every year, complications from cirrhosis lead to over 400,000 hospitalizations and 27,000 deaths. In Egypt, 76.92% of patients admitted to the National Liver Institute Hospital for treatment at in-patient department had liver cirrhosis (Centers for Disease Control & Prevention, 2014). Nurse play role in the patient educator , hence this study aimed to evaluate the effect of nursing intervention on outcome for patient receiving direct acting antiviral drugs for treatment of chronic hepatitis C .
Aim of the study
This study aimed to evaluate the effect of nursing intervention on outcomes for patients receiving direct acting antiviral drugs for treatment of chronic hepatitis C. Research Hypothesis 1. Patients of study group who receiving nursing intervention have good outcomes rather than control group.
Statistically significant difference between two group regarding patient's knowledge about information of hepatitis (c) and liver cirrhosis Patients and methods Research design
Quasi -experimental research design was used to conduct this study Setting
The study was carried out at the Unit of Treatment of Viral Hepatitis at Assuit Health Directorate.
Sample
A convenient sample of 60 patients with HCV related liver cirrhosis that was under treatment with DAAs based regimen was included in this study. They were divided into two groups; study group (30 patients) who were receiving nursing intervention and control group (30 patients) who were exposed to the routine care in the unit. Part4 -Child-Turcotte-Pugh -score This score adopted from (Friedman, 2012) .The Child-Pugh Score is a scoring system used to determine the prognosis of cirrhosis. This part was concerned to assess the severity of the disease and predict mortality in patients with liver cirrhosis. This score include three biochemical markers (serum albumin, total bilirubin, and prothrombin time, INR) and clinical features as the presence of ascites and hepatic encephalopathy. The Child score ranges from 5-15 with individual scoring 5-6 being class A, 7-9 are being class B and 10-15 class C. As mention in interpretation in the following table Tool (II): Nursing intervention about disease and drugs: includes two parts: Part 1-Nursing intervention which includes instructions related to liver cirrhosis and its complications. Part 2-Nursing intervention which include instructions related to direct acting antiviral drugs for treatment of chronic hepatitis C including name, action, dose, route of administration and frequency, side effects of the drug and nursing precaution for each type of drugs.
Inclusion criteria

Table (1) : Child-Turcotte-Pugh (CTP) classification of the severity of cirrhosis
Interpretation
Points
Class One year survival Two year survival 5-6 A 100% 85% 7-9 B 81% 57% 10-15 C 45% 35%
Methods
The study was conducted throughout three main phases which are preparatory phase, implementation phase and evaluation phase. and drugs and its result was0.87which were accepted. -The pilot study: Pilot study was carried out on 10%of study sample who met the predetermined selection criteria to test applicability of the tools then necessary modifications were done according to the results of the pilot study and expertise opinions. The participants of pilot study were excluded from the study. Ethical consideration -Research proposal was approved by ethical committee of the faculty of nursing . -Informed consent was taken from patient participating study, after explaining the nature and purpose of the study. -Confidentiality and anonymity were being assured.
-Patients were assured that, the data of his research will not be refused without second permission. -Patients were informed that they refuse to participate and or withdraw from the study without any rational any time.
Implementation phase
This phase was involved :( for both groups)  The study was carried out during morning in the unit, when patients visit to unit.  The patients admitted early in the morning at 9:00 at unit  Patient comes to the unit every month at the first 3 month for those who received 3 month regimen and for other 3 month for follow up.  The researcher explaining the purpose of the study to Patient when coming to receive drug from unit.  The researcher filled out sheet through interviewing each patient individually to obtain the necessary information.  The average of time taken for completing each tool was around 5-10 minutes depending on the patient's responses to question. 
Evaluation phase
Study and control groups were followed up monthly for 6 months to evaluate effects of nursing intervention on patient's outcomes and to insist on participant's compliance to the given instructions by using tool (1) .
Statistical Analysis
All the statistical analysis was performed using SPSS package version 20. The collected data were coded and analyzed. Data were presented using descriptive statistics in the form of frequencies and percentages for qualitative variables and mean and standard deviations for quantitative variables. Qualitative variables were compared using Chi-square and ANOVA tests. Spearman correlation coefficient test was used to test correlation between variables. Statistical significance was considered at P. value < 0.05. 
Results
Figure (1 ):comparison between pre-test and post-test in study and control groups regarding Level of knowledge about hepatitis at the Unit of Treatment of Viral Hepatitis in assuit city 2016. Less than 60%unsatisfactory
More than or equal 60%satistfactory Showed that, all Child -Turcotte -Pugh scores for studied subjects were high statistical significant differences between study and control group from week 0 to week 24 (p=0.007, p=0.006, p=0.009, P= 0.011, p=0.015, p=0.004 respectively) . It was observed there were high statistical significant differences between study and control groups regarding Child -Turcotte -Pugh scores.
Discussion
Hepatitis C virus infection is one of the main causes of chronic liver disease worldwide. The long-term impact of HCV infection is highly variable, ranging from minimal histologic-all changes to extensive fibrosis and cirrhosis with or without HCC. (HCV) -Induced decompensated liver cirrhosis (LC) is a lifethreatening illness with an average 5-year survival rate of 50%. Although liver transplantation has been the only curative therapy for these patients, treatment is important issues where the recently-developed (DAAs) are now helping patients cope with these difficult situations. Because DAAs have far fewer adverse effects and are better tolerated than interferon (IFN), they can be used to treat the elderly or patients with comorbidities (Goldberg & Chopra, 2014) .
The teaching-learning process is considered as means by which the patient can acquire knowledge, skills, and be encouraged to participate in their treatment, making decisions and assuming responsibilities. With the knowledge developed, the patient may change its health behavior (WHO, 2012). Therefore; this study aimed to evaluate the impact of nursing intervention on outcomes among patients receiving DAADs for Treatment of Chronic Hepatitis C.
The results of the present study showed that most of patient's age ranged between 38 and 66 years, with Mean ± SD 54.63 ± 7.06 .This finding was higher than the results of Heneedy, (2009) who reported that the mean age of study sample was 49.8±8.3for study group and 49.3±8.7 years for control group.
As regard to sex, the studied subjects showed that more than half of studied subjects were males followed by less than half of studied subject were females. This finding could be attributed to that more than half of studied subject were males because they are more discovery of the (HCV) through performing investigation for traveling abroad. This was agree with (Alavian, et al., 2010) who reported that more than three fourth of studied subject were male. According to educational level the present study showed that more than two fifth of patient were Illiterate. This finding could be attributed to that more than two third of studied patients were from rural areas and of low economic status. Furthermore, the present revealed that all of study patients were having liver cirrhosis, splenomegaly and other manifestations of liver cell failure; ascites was clear that around fifth of them while decline during and at end of treatment to more than one quarter of study group . Regarding liver function test. It was noticed slightly difference between before, during and at end of treatment. Also the present study showed significant improvement of prothrombin concentration, INR, albumin after application of nursing intervention. This finding could be attributed to side effect of new treatment regimen agent very limited and due to effect of nursing intervention received from unit by the researcher. In addition, regarding to total Child -Turcotte -Pugh scores the results of the present study showed that high statistical significant improvement between study and control group after application of the who found that the combination of SOF /DAC/RBV treatment was tested in large-scale clinical trials, resulting in SVR rates of more than 90% in patients with genotype 1 infection. But this was not agreeing with Dore, Foster. (2014).who reported that the SVR rate was significantly higher among cirrhotic patients in the 24-week treatment group than in the 12-week group (95% vs. 88%). The current study revealed a great lack of patient's knowledge as regard to liver cirrhosis pre implementation of the nursing intervention either in both study and control groups. The majority of patients of study and control groups were having an unsatisfactory knowledge score levels in pre -test, This finding could be attributed to lack of patient's education about liver cirrhosis and the majority of study and control groups were illiterate and from rural area . The result of the present study revealed that, the majority of study group patients after implementation of the nursing intervention were following the instructions given to them about therapeutic regimen, the food allowed and avoided food, and instructions about indicated and contraindicated medications. These results were in line with Weheida, et al., (2009) who found that, after care implementation there was an improvement in compliance of study group patients to therapeutic regimen, this could be explained by the fact that patients were given instructions about medication, also instructions given about food allowed and food that should be avoided to avoid further threatening Complications. This result also, was in line with Jay & Marks, (2013) who recorded that cirrhotic patients with ascites had great learning needs due to the poor knowledge about their condition and a low level of performing selfcare and prevention of life threatening hazards of liver cirrhosis.
In the current study after implementation of the nursing intervention, patient's knowledge levels were significantly improved. This findings supported by Hairon, (2008) and who reported that, education is the key to successful treatment of the disease, and the nurse plays role as patient educator. Patients and their families need accurate information about the disease and about the strategies to minimize its impact. In the present study, patient's pre intervention denoted the vast majority of them lack any essential knowledge about their medication, action, dose, route, frequency, possible side effects and how to manage and were provided to cover all aspects of HCV (definition, causes, signs and symptoms, treatment, action, dose, route, frequency, side effects and how to deal with it) which eventually increase patients knowledge. The nursing intervention presented to patients had given a significant increase in their knowledge about DAAD based regimen. These results were consistent with Fareed, (2010) who showed a statistical significant difference between before and after conduction the nursing management protocol that indicates an improvement of patients total mean score of knowledge after intervention. Also this finding was consistent with that obtained by Elshiekh, (2013) who found that repetition teaching on patient medication have significantly increase their knowledge regarding dose, special precautions and possible side effects of drug. The result of the present study revealed that, participation in the nursing intervention demonstrated a significant improvement in study group knowledge of treatment for HCV as compared to prior participation of study and control groups in the nursing intervention. Findings may be informing for nurses to understand that, patient and family teaching is an important nursing role that may make the difference in the ability of the patient and family to adapt to chronic conditions. Well-informed, educated patients are more likely than uninformed patients to be concerned about their health and to do what is necessary to maintain it. They are also more likely to manage symptoms, recognize the onset of complications and seek health care early. Knowledge is the key to make informed choices and decisions during all phases of the chronic illness trajectory.
Conclusion
The Present study we can finally conclude that, designed nursing intervention for patient receiving DAADs for Treatment of Chronic Hepatitis C achieved its objective by improving patient health status and their knowledge of treatment for hepatitisC.
Recommendations
 The current study recommended replication of nursing intervention of this study on larger probability sample from different geographical areas and in different hospital settings to allow greater generalizability of the results.  Education of public population through mass media, posters and awareness campaigns about risk factors and prevention method of chronic hepatitis.  Conduct further research to develop a training program about viral hepatitis (C) and methods of prevention from it.
